The wait is finally over. Sneakerheads, collectors, and streetwear fans can all breathe a collective sigh of excitement: Nike ...

GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending for the first time, according to a March 25 report from Evernorth.

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that have taken the leap off the patent cliff. Big Pharma is staring down the ...

You're already imagining what it sounds like. We are. Looks like Ferrari has submitted a patent design for a new V12 that uses oval-shaped pistons. Pistons, as you're probably aware, are famously ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.

Nintendo's lawsuit alleging patent infringement in Palworld was unexpected given the timing and subject matter, and nobody was more surprised than developer Pocketpair, who says "no one even ...

Because nothing is worth that, it doesn’t matter how many No 1s you get, it ain’t worth that.” But all five of them were emotionally and mentally suffering. “We should have had six months ...